HelmholtzZentrum munich
WCMC

Connecting genetic risk to disease endpoints through the human blood plasma proteome

ONLINE SUPPLEMENTARY INFORMATION

Ideogram
Proteome annotation
Locus annotations

Locus 246

Top associations per target

Target cis/​trans Study SNP SNP location Maj/​min allele MAF N βinv seinv Pinv fclog Plog Praw
C7 cis Discovery rs13157656 5:40,964,852 A/C 0.25 997 -0.401 0.048 1.3×10-16 -1.080 1.8×10-12 5.7×10-15
C7 cis Replication rs3828510 5:40,973,603 G/A 0.32 337 -0.344 0.071 1.8×10-6 -1.080 4.3×10-5 1.7×10-4

 

Regional association plots

 

Boxplots and histograms for top associations

Complement component C7 (C7)

inverse-normalized probe levels log2 transformed probe levels raw probe levels
Discovery study
Replication study

Complement component C7 (C7)

Target (abbrv.) C7
Target (full name) Complement component C7
Somalogic ID (Sequence ID) SL000323 (2888-49_2)
Entrez Gene Symbol C7
UniProt ID P10643
UniProt Comment
  • Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells. C7 serves as a membrane anchor.
Wiki Pathways
  • Complement Activation, Classical Pathway
  • Complement and Coagulation Cascades
Reactome
  • Regulation of Complement cascade
  • Terminal pathway of complement
Pathway Studio
  • Alternative Complement Pathway
  • Classical Complement Pathway
  • Lectin-Induced Complement Pathway

All locus annotations are based on the sentinel SNP (rs13157656) and 22 proxy variant(s) that is/are in linkage disequilibrium r2 ≥ 0.8. Linkage disequilibrium is based on data from the 1000 Genomes Project, phase 3 version 5, European population and was retrieved using SNiPA's Block Annotation feature.
Download the detailed results of SNiPA's block annotation (PDF)

Linked genes

Genes hit or close-by

 

Results from other genome-wide association studies

Trait P Study Source
Lung function, forced expiratory volume in 1 second (FEV1) percent predicted (in nonasthmatic participants) 1.5×10-5 22424883 (PMID) GRASP2 nonQTL
Decrease in FEV1 (in nonasthmatic participants) 4×10-5 22424883 (PMID) GRASP2 nonQTL
Decrease in FEV1 (in nonasthmatic participants >=30 years old) 3.3×10-4 22424883 (PMID) GRASP2 nonQTL